Print
Editor's Picks
1 2 3 4 5 6 ... » Next
1 2 3 4 5 6 ... » Next
1 2 3 4 5 6 ... » Next
- Appeals court strikes health insurance requirement
Associated Press - Hot Chemotherapy Bath: Patients See Hope, Critics Hold Doubts
The New York Times - New H.I.V. Cases Steady Despite Better Treatment
The New York Times - Alzheimer’s Research Among Science Efforts at Stake in Debt Deal
Bloomberg - FDA plans oversight of some mobile medical apps
Reuters - Lilly CEO Says Immigration Boosts Innovation
Bloomberg - Race to copy biotech drugs creates odd bedfellows
Reuters - Pharma Needs an Innovation Intervention
Bloomberg BusinessWeek - Report discounts value of many 'biomarkers' in predicting disease
The Los Angeles Times - The WHO Says Cellphones—and Pickles—May Cause Cancer
Slate - AstraZeneca pulls plug on free trips for doctors
Reuters - Sanofi’s Zerhouni On Translational Research: No Simple Solution
The Wall Street Journal - Desperate Americans Buy Kidneys From Peru Poor in Fatal Trade
Bloomberg - Analysis: Is Pharma's big brand era over?
Reuters - Special report: Big Pharma's global guinea pigs
Reuters - Court backs federal embryonic stem cells funds
Reuters - A Fight Over How Drugs Are Pitched
The New York Times - White House announces plans to reduce prescription drug
Reuters - U.S. Cancer Doctors Back Genetic Tests to Assess Lung Cancer Patients
Bloomberg - Endo cuts patent risk with $2.6 billion American Medical
Reuters - Republican Medicare Plan Could Shape 2012 Races
The New York Times - Sanofi Chief details innovation strategy
Boston Business Journal - Cephalon Board Rejects Valeant’s Unsolicited $5.7 Billion Bid As Too Low
Reuters - Mouse Stem-Cell Discovery May Lead to Blindness Therapies, Researchers Say
Bloomberg - Drugs’ Cost and Safety Fuel a Fight
The New York Times - G.O.P. Blueprint Would Remake Health Policy
The New York Times - Senate Passes Change to Health Law
The New York Times - Valeant Pharma Offers to Acquire Cephalon for $5.7 Billion
Bloomberg - Bayer plans to raise BRIC revenue to 10 bln-paper
Reuters - States Weigh Fighting Meth With Drug Prescriptions
The New York Times - Protalix Plans Human Clinical Tests of Medication for Rare Fabry's Disease
Bloomberg - Branded drug prices soar as generic pressure rises
Reuters - China to ban smoking at indoor public places
Reuters - A Panel Decides Washington State’s Health Care Costs
The New York Times - Supreme Court Rules Against Zicam Maker
The New York Times - Anxiety Over Radiation Drives a Sales Surge for a Drug Against Thyroid Cancer
The New York Times - HIV Drug Development Falters as Merck, Bristol-Myers Struggle With Success
Bloomberg - Alzheimer's drug hits two forms of toxic protein
Reuters - Number of Survivors of Cancer Rises 20 Percent
The New York Times - Mexico Puts Its Children on a Diet
The New York Times - Sanofi to Buy Genzyme for Sweetened $20.1 Billion After Nine-Month Pursuit
Bloomberg - For Cold Virus, Zinc May Edge Out Even Chicken Soup
The New York Times - Ecuadorean Villagers May Hold Secret to Longevity
The New York Times - Obama budget targets brand name medicines
Reuters - Medical Device Makers Shun United States
The New York Times - Drugmakers’ Fever for the Power of RNA Interference Has Cooled
The New York Times - Genzyme, Sanofi boards to meet on Sunday -sources
Reuters - States Diverge on How to Deal With Health Care Ruling
The New York Times - Medical Detectives Find Their First New Disease
The New York Times - Federal Judge Rules Health Law Violates Constitution
The New York Times - U.K. Health Secretary Asked Drugmakers to Accept Lower Prices
Bloomberg - Sanofi Extends $18.5 Billion Genzyme Takeover Bid Again as Talks Continue
Bloomberg - Heart disease costs to triple in U.S. by 2030: report
Reuters - Federal Research Center Will Help Develop Medicines
The New York Times - Verbal Sparring Over Potential Senate Vote on Health Care
The New York Times - Copying biotech medicine attracts more drugmakers
Reuters - U.S. Backs Drug Firms in Lawsuit Over Prices
The New York Times - Doubt on Anti-Aging Molecule as Drug Trial Stops
The New York Times - Down the Hatch and Straight Into Medical History
The New York Times - Sanofi, Genzyme Chiefs Say Talks Are Advancing on Fee
Bloomberg - Thermo Fisher Scientific Said to Pursue Sale of Units for Up to $1 Billion
Bloomberg - US top court to weigh drugmaker disclosures
Reuters - Healthcare law repeal clears hurdle in US House
Reuters - Republicans Are Given a Price Tag for Health Law Repeal, but Reject It
The New York Times - Health Care Law Ruled Unconstitutional
The New york Times - Bayer to Spend $4.1 Billion on Research in 2011 as Xarelto Trials Near End
Bloomberg - Sanofi's chief gets U.S. lobby role as Kindler exits
Reuters - Pfizer’s Chairman and Chief Retires Unexpectedly
The New York Times - Arsenic-eating bacteria point to new life forms
The Scientist - Merck to buy SmartCells to gain diabetes product
Reuters - Overweight People, Not Just Obese, More Likely to Die Sooner, Study Says
Bloomberg - Orexigen Options Suggest Contrave Diet Pill May Avoid Arena, Vivus Delays
Bloomberg - Biosimilars will be challenging for FDA, speakers say
The Hill - EU guidelines clear way for biosimilar antibodies
Reuters - Research and Develop
The Economist - Genzyme open to Campath clause in Sanofi bid-paper
Reuters - UCLA researcher receives threatening package; animal activists said to claim responsibility
The Los Angeles Times - Senate Passes Sweeping Law on Food Safety
The New York Times - UnitedHealth Says Diabetes Will Cost $3.4 Trillion Over the Next Decade
Bloomberg - Epilepsy’s Big, Fat Miracle
The New York Times - Genzyme in Talks With Takeda About $18.5 Billion Sale, Mail on Sunday Says
Bloomberg - Antibiotics Research Subsidies Weighed by U.S.
The New York Times - Lilly's Diabetes Setbacks May Spur Shopping Spree Beyond Amylin
Bloomberg - U.S. Supreme Court justices signaled they may split on the scope of the pharmaceutical industry’s shield from lawsuits over injuries allegedly caused by vaccines.
Bloomberg - Sanofi Goes Hostile With Genzyme Bid
The New York Times - Pioneer of In Vitro Fertilization Wins Nobel Prize
The New York Times - Children Exposed to Virus Weigh 52 Pounds More, Obesity Researchers Find
Bloomberg - Biotech salmon faces scrutiny at FDA panel
Reuters - New Drugs Stir Debate on Rules of Clinical Trials
The New York Times - FDA staff question Arena diet drug, shares plunge
Reuters - Top Genentech research exec departing for academia
Reuters - Health Plan Won’t Fuel Big Spending, Report Says
The New York Times - Lilly Invests $150 Million With Venture Firms Seeking New Drug Candidates
Bloomberg - Genzyme Investors Push for Sanofi Bid of $75 a Share
Bloomberg - Sanofi's CEO Viehbacher Pitches Genzyme Investors in New York on Takeover
Bloomberg - Valeant, Biovail to cut 25 pct jobs of combined co
Reuters - Elan gets injunction vs directors, slams investor
Reuters - Sanofi Chief Extends Hand to Bypass Genzyme `Brick Wall'
Bloomberg - U.S. Court Rules Against Obama’s Stem Cell Policy
The New York Times - Takeda Says Lifestyle-Disease Drugs Will Drive Growth
Bloomberg
1 2 3 4 5 6 ... » Next
.gif)
.png){kind=small} |
 |